Finance

Beta
Lists
CEVA:NASDAQ
Ceva Inc
$42.32
-3.59%
(-1.58) 1D
$41.47
-2.01% (-0.85)
After hours
Closed: Jun 26, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CEVA...
Open
$42.10
High
$43.20
Low
$41.50
Mkt. cap
1.18B
Avg. vol.
924.74K
Volume
1.17M
52-wk high
$51.60
52-wk low
$17.02
EPS
-$0.46
Beta
2.00
Shares outstanding
27.86M
No. of employees
400
Open
$42.10
High
$43.20
Low
$41.50
Mkt. cap
1.18B
Avg. vol.
924.74K
Volume
1.17M
52-wk high
$51.60
52-wk low
$17.02
EPS
-$0.46
Beta
2.00
Shares outstanding
27.86M
No. of employees
400
News stories
From sources across the web
Profile
Ceva, Inc. is a publicly traded semiconductor and software intellectual property company listed on NASDAQ under the ticker symbol CEVA. Headquartered in Rockville, Maryland, Ceva develops and licenses signal processing platforms and AI processors for a broad range of smart edge applications. Its licensable technologies include wireless connectivity IPs of Bluetooth, Wi-Fi, UWB and 5G, scalable Edge AI NPU IPs and sensor fusion solutions, serving diverse markets such as automotive, consumer IoT, industrial, infrastructure, mobile, and PC. Wikipedia
About Ceva Inc
CEOAmir Panush | Gideon Wertheizer
Employees400
FoundedNov 22, 1999
HeadquartersMountain View, California, United States
SectorSemiconductor
Analyst ratings
Based on 8 analysts giving stock ratings to CEVA in the past 3 months
Strong buy
Buy
7
Hold
1
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for CEVA in the last 3 months.
Highest
Current $42.32
$60.00 (+41.78%)
Average
$46.63 (+10.18%)
Lowest
$36.00 (-14.93%)
Analyst
Recommendation
Action
Price target
Projected
Date
Suji Desilva
Roth MKM
Buy
Maintained
$60.00
+41.8%
06/18/2026
Suji Desilva
Roth MKM
Buy
Maintained
$60.00
+41.8%
06/18/2026
Charles Shi
Needham
Buy
Initiated
$55.00
+30%
06/15/2026
Ruben Roy
Stifel Nicolaus
Buy
Maintained
$42.00
-0.8%
06/03/2026
Natalia Winkler
UBS
Buy
Reiterated
$48.00
+13.4%
05/12/2026
Samik Chatterjee
J.P. Morgan
Hold
Maintained
$36.00
-14.9%
05/12/2026
Martin Yang
Oppenheimer
Buy
Reiterated
$42.00
-0.8%
05/12/2026
Joshua Buchalter
TD Cowen
Buy
Reiterated
$45.00
+6.3%
05/12/2026
Kevin Cassidy
Rosenblatt Securities
Buy
Reiterated
$45.00
+6.3%
05/11/2026
Last report
May 11, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.04 / $0.02
+121.98%beat
Revenue / Est. (USD)
27.02M / 26.12M
+3.46%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
25.68M
28.38M
31.29M
27.02M
Cost of goods sold
3.55M
3.39M
3.73M
3.73M
Cost of revenue
3.55M
3.39M
3.73M
3.73M
Research and development expenses
18.76M
19.53M
18.93M
19.84M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.70M
7.40M
8.88M
8.43M
Operating expense
26.61M
27.08M
27.96M
28.38M
Total operating expenses
30.16M
30.47M
31.69M
32.11M
Operating income
-4.48M
-2.08M
-398.00K
-5.08M
Other non operating income
-
-
-
-
EBT including unusual items
-2.57M
-838.00K
1.05M
-3.14M
EBT excluding unusual items
-2.59M
-1.01M
889.00K
-3.31M
Income tax expense
1.14M
1.67M
2.15M
1.32M
Effective tax rate
-44.18%
-199.40%
204.27%
-41.83%
Other operating expenses
-
-
-
-
Net income
-3.70M
-2.51M
-1.10M
-4.46M
Net profit margin
-14.42%
-8.84%
-3.51%
-16.50%
Earnings per share
0.07
0.11
0.18
0.04
Interest and investment income
1.32M
1.34M
1.59M
1.97M
Interest expense
-
-
-
-
Net interest expenses
1.32M
1.34M
1.59M
1.97M
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.38M
-929.00K
751.00K
-4.22M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
Give me an overview of CEVA
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more